Showing 17–32 of 102 resultsSorted by popularity
5-Amino-1MQ is a potent and selective NNMT inhibitor that elevates intracellular NAD+ levels, driving mitochondrial biogenesis and fatty acid oxidation. An essential tool for metabolic remodeling and adipose tissue reduction research.
Tirzepatide is a peptide that activates both GLP-1 and GIP receptors. It was developed to fight type 2 diabetes by lowering blood sugar levels, boosting insulin sensitivity, and reducing hunger. In addition to cardiovascular benefits, recent trials have demonstrated impressive results when used for weight loss.
Tirzepatide is a peptide that activates both GLP-1 and GIP receptors. It was developed to fight type 2 diabetes by lowering blood sugar levels, boosting insulin sensitivity, and reducing hunger. In addition to cardiovascular benefits, recent trials have demonstrated impressive results when used for weight loss.
CJC-1295 without DAC (Modified GRF 1-29) is a tetrasubstituted GHRH analog engineered to stimulate natural, pulsatile growth hormone secretion from the anterior pituitary. Its 30-minute half-life mimics physiological GH rhythms without pituitary receptor downregulation.
Sterile 0.01M Acetic Acid solution for pH-sensitive peptide reconstitution. Maintains peptide stability during dissolution.
Thymalin is a synthetically derived analog of the naturally occurring thymic polypeptide bioregulator. >99% purity confirmed by HPLC analysis.
SS-31 (Elamipretide) is a cell-permeable tetrapeptide that selectively targets cardiolipin on the inner mitochondrial membrane, preventing cytochrome c peroxidase activity and restoring electron transport chain function. A primary tool for mitochondrial bioenergetics and anti-aging research.
BPC 157 operates primarily by upregulating key growth factor cascades. >99% purity confirmed by HPLC analysis.
AOD 9604 is a stabilized C-terminal fragment of human growth hormone (177-191) with an N-terminal tyrosine modification for enhanced proteolytic resistance. It selectively activates beta-3 adrenergic receptors on adipocytes to drive lipolysis without affecting IGF-1 or insulin sensitivity.
Tirzepatide exerts its physiological influence by simultaneously activating the GLP-1 and GIP receptors. >99% purity confirmed by HPLC analysis.
Gonadorelin is a synthetic GnRH decapeptide that binds pituitary gonadotroph receptors to trigger pulsatile release of LH and FSH, driving gonadal steroidogenesis. Its short 10-40 minute half-life makes it ideal for investigating acute hormonal surges and pituitary responsiveness.
AOD 9604 is a stabilized C-terminal fragment of human growth hormone (177-191) with an N-terminal tyrosine modification for enhanced proteolytic resistance. It selectively activates beta-3 adrenergic receptors on adipocytes to drive lipolysis without affecting IGF-1 or insulin sensitivity.
EPO for research use.
Thymosin Alpha-1 is a synthetic 28-amino acid polypeptide that binds Toll-like receptor 9 on dendritic cells to drive T-lymphocyte maturation, MHC Class I expression, and Th1 cytokine production. A primary orchestrator of adaptive immune response for antiviral and immunomodulation research.
Sermorelin selectively targets the anterior pituitary gland. Manufactured at >99% purity (HPLC certified).
End of content
End of content
No products in the cart.
